Member Info for stephen11

Before the 31st - to get the SP up before the big bounce.

Something like:

- a US partner for FDA (we have history with Beckman Coulter)

- a sniff of European or Worldwide sales

- some more NHS Trusts coming onboard for the prem hearing loss adverse drug reaction test

- etc, etc.

GLA.

Stephen11.

Your being very selective with your wording to suit your own agenda StockSaint - anyone with half a brain can see that. Quoting out of context of the full information.

I actually thought you were an embittered ex-shareholder - I now believe you are a paid deramper.

Stocksaint,

As you well know, GDR applied for NICE accreditation. The competitors are evaluated and mentioned as part of the due deligence process.

I hope no one gets fooled by your misinformation.

More smoke and mirrors 🪞

StockSaint tries to state that the NICE guidance is not about GDR, when GDR applied for the NICE accredidation!!!!

You couldn't make this up!

StockSaint,

You have lost the plot and are posting misinformation.

The whole point of pharmacogenetic testing is that it prevents an adverse drug reaction by prescribing the correct medication in a timely manner.

For those who are unfortunate enough to suffer a stroke, a large proportion are allergic to Clopidogrel, and prescribing this would produce said adverse reaction. Now - these people need an alternative medication asap - not after results come back from a lab in a day or two - hence, the GDR test - its as simple as that.

Now - if you want anymore information i'll need a blackboard and chalk.

In the meantime, please stop insulting everyone's intelligence with your misinformation.

Stephen11.

NICE!

Oooh Stocksaint is able to type again.

He's just finished crying into his cornflakes...lol.

He doesn't like to see the SP go up.

Its a bit like the old saying misery enjoys misery.

Well done to all genuine holders.

Deflect from reality - that's rich coming from you!

Your the biggest Walter Mitty style fantasist type character to ever type on this board.

Starresnstoff, Starrs, Stocksaint.

Is that the best you can do Starrs...LOL.

You don't like it when people call a spade a spade - do you?

Agree Muminr - even 20p could be possible after NICE.

Fair points Sharedealer2019 - i can appreciate your perspective.

It can be quite difficult to get your head around the impact of dilution.

Basically, prior to the fund raise we had 153m shares on issue, compared to 543.14m now. This means we have a multiple of 3.55 more shares on issue at present.

What does this mean in terms of the "OLD" and "NEW" SP.

£2.00 in old money would now be an SP of 56p now

£1.00 = 28p

50p = 14.29p

25p = 7p

20p = 5.63p

10p = 2.82p

5p = 1.41p

So, for me, 15p is more than doable this year. We previously hit £2.00 on the rumour of sales for the Covid test, but those were crazy, when you consider Novacyt went from a few pence to over £10.00.

Why wouldn't we get the full NICE accreditation for the stroke assay - how much more evidence do they need?

The test distinguishes individuals who would have an adverse reaction from clopidogrel, and allows for the administration of a more appropriate drug, in a timely manner.

Whats not to like or be excited about GDR having a regular income stream from July?

GLA.

Stephen11.

Stocksaint,

If this share is such a lame duck 🦆, then why do you spend a large proportion of your life posting about it?

Would your time not be better spent attempting to make a profit elsewhere?

Stephen11.

PS...no sidestepping or bullsh&t please!

Hit the nail on the head Eureka1,

I've been here for over 4 years and know all about this colourful character.

Stocksaint is a reincarnation of Starresenoff, indeed - the same person. Both have posted on BUR - i even called him out on the BUR board.

I can remember him getting barred from the platform.

He did have a very large holding at one time, but couldn't afford to average down. He sold out for a major loss.

He needs to get a hobby outside of shares really - something he can't lose money on.

GLA.

Stephen11.

You sidestepped the question very nicely Stocksaint - almost like a politician.

Stocksaint,

If this share is such a lame duck 🦆, then why do you spend a large proportion of your life posting about it?

Would your time not be better spent attempting to make a profit elsewhere?

Stephen11.

There is a lot to be optimistic about for those invested in GDR at the moment, with NICE validation and the recent news on fast track for the FDA being the icing on the cake.

NICE accreditation will also open the door for worldwide sales as the accreditation process is extremely stringent and therefore a world renowned quality standard.

However, we do have a few disgruntled 😣 ex shareholders polluting this forum. The sort that have held at a high average, sold at a loss, and could not afford to average down.

You’ve all met these types - they don’t like to see others do well and are spitting the dummy out of the pram. Sore losers.

Conversely, I do like to see others prosper. Well done to those longtermholders who have kept the faith and good luck 🤞 to all those guys who bought in at the previous lows.

It’s only just begun. Looking forward to a positive week.

GLA.

Stephen11.

It’s going back up now and will probably end the day +.

I don’t know of any shares that go up in a straight line.

If any of you find one, please let me know.

The difference now is we are on the cusp of NICE accreditation, which is a world renowned validation that will open a lot of doors 🚪.